SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: james who wrote (2947)11/21/1997 11:04:00 PM
From: Peter Singleton  Read Replies (1) | Respond to of 6136
 
So, James, are you suggesting that Roche is the perfect PI partner for AGPH? : )

As I add things up, their PI is too weak to be a standalone PI in a 1 PI combination therapy, but it offers additive or synergistic benefits as part of a 2 PI combination therapy.

Thanks for the post ....

Peter